90 related articles for article (PubMed ID: 15949258)
1. [Effect of 2-methoxyestradiol on cell differentiation of myeloma cell line CZ-1].
Gao WR; Hou J
Zhonghua Xue Ye Xue Za Zhi; 2005 Apr; 26(4):197-9. PubMed ID: 15949258
[TBL] [Abstract][Full Text] [Related]
2. Preliminary investigation of 2-methoxyestradiol inducing differentiation of myeloma cell line CZ-1.
Hou J; Xiong H; Gao WR; Jiang H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Feb; 14(1):65-9. PubMed ID: 16584594
[TBL] [Abstract][Full Text] [Related]
3. [Molecular mechanism of myeloma cell line differentiation induced by 2-methoxyestradiol].
Gao WR; Hou J; Xiong H
Zhonghua Xue Ye Xue Za Zhi; 2005 Oct; 26(10):598-601. PubMed ID: 16532968
[TBL] [Abstract][Full Text] [Related]
4. [Effect of 2-methoxyestradiol on differentiation of primary myeloma cells].
Gao WR; Hou J; Xiong H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):262-6. PubMed ID: 16638193
[TBL] [Abstract][Full Text] [Related]
5. [Regulation of c-myc expression by Blimp-1 during the differentiation of myeloma cells].
Zhou X; Zhou F; Jiang H; Hou J
Zhonghua Xue Ye Xue Za Zhi; 2007 May; 28(5):318-22. PubMed ID: 17877160
[TBL] [Abstract][Full Text] [Related]
6. 2-Methoxyestradiol at low dose induces differentiation of myeloma cells.
Hou J; Xiong H; Gao W; Jiang H
Leuk Res; 2005 Sep; 29(9):1059-67. PubMed ID: 16038732
[TBL] [Abstract][Full Text] [Related]
7. Transcription factors Xbp-1, Blimp-1, and BSAP are involved in the regulation of plasmacytic differentiation induced by 2-methoxyestradiol in myeloma cell lines.
Jiang H; Gao W; Sze DM; Xiong H; Hou J
Int J Hematol; 2007 Dec; 86(5):429-37. PubMed ID: 18192112
[TBL] [Abstract][Full Text] [Related]
8. [Effect of 2-methoxyestradiol on proliferation and apoptosis of myeloma cell lines].
Gao WR; Hou J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Apr; 13(2):293-7. PubMed ID: 15854295
[TBL] [Abstract][Full Text] [Related]
9. Coordination of upregulated XBP-1 and downregulated c-myc during myeloma cell differentiation induced by 2-methoxyestradiol.
Zhou X; Jiang H; Hou J
Leuk Res; 2007 Sep; 31(9):1259-65. PubMed ID: 17257674
[TBL] [Abstract][Full Text] [Related]
10. [Investigation of the effect of 2-methoxyestradiol and arsenic trioxide on the apoptosis-associated gene expression profile of myeloma cells].
Xiong H; Hou J; Gao WR; Chen QB
Zhonghua Xue Ye Xue Za Zhi; 2005 Apr; 26(4):200-4. PubMed ID: 15949259
[TBL] [Abstract][Full Text] [Related]
11. [Effect of low-dose 2-methoxyestradiol on the expressions of two isoforms of PRDM1 gene in myeloma].
Jiang H; Hou J
Zhonghua Xue Ye Xue Za Zhi; 2009 Jan; 30(1):38-41. PubMed ID: 19563034
[TBL] [Abstract][Full Text] [Related]
12. Multiple myeloma cells undergo differentiation upon exposure to rosiglitazone and all-trans retinoic acid.
Huang H; Wu D; Fu J; Chen G
Leuk Lymphoma; 2009 Jun; 50(6):966-73. PubMed ID: 19373597
[TBL] [Abstract][Full Text] [Related]
13. 2-methoxyestradiol inhibits the anaphase-promoting complex and protein translation in human breast cancer cells.
Bhati R; Gökmen-Polar Y; Sledge GW; Fan C; Nakshatri H; Ketelsen D; Borchers CH; Dial MJ; Patterson C; Klauber-DeMore N
Cancer Res; 2007 Jan; 67(2):702-8. PubMed ID: 17234781
[TBL] [Abstract][Full Text] [Related]
14. [Differentiating effect of PPARgamma ligand rosiglitazone and all trans-retinoic acid on myeloma cells and its possible mechanism].
Huang HW; Chen GH; Chang HR; Chow HC; Leung AY; Liang R; Wu DP
Zhonghua Zhong Liu Za Zhi; 2009 Dec; 31(12):885-9. PubMed ID: 20193324
[TBL] [Abstract][Full Text] [Related]
15. 2-Methoxyestradiol overcomes drug resistance in multiple myeloma cells.
Chauhan D; Catley L; Hideshima T; Li G; Leblanc R; Gupta D; Sattler M; Richardson P; Schlossman RL; Podar K; Weller E; Munshi N; Anderson KC
Blood; 2002 Sep; 100(6):2187-94. PubMed ID: 12200384
[TBL] [Abstract][Full Text] [Related]
16. [Mechanism study on low dose tunicamycin inducing myeloma cells differentiation via unfolded protein response].
Zou JF; Jiang H; Hou J
Zhonghua Xue Ye Xue Za Zhi; 2010 Oct; 31(10):675-9. PubMed ID: 21223718
[TBL] [Abstract][Full Text] [Related]
17. Novel therapy with 2-methoxyestradiol for the treatment of relapsed and plateau phase multiple myeloma.
Rajkumar SV; Richardson PG; Lacy MQ; Dispenzieri A; Greipp PR; Witzig TE; Schlossman R; Sidor CF; Anderson KC; Gertz MA
Clin Cancer Res; 2007 Oct; 13(20):6162-7. PubMed ID: 17947482
[TBL] [Abstract][Full Text] [Related]
18. Identification of genes regulated by 2-methoxyestradiol (2ME2) in multiple myeloma cells using oligonucleotide arrays.
Chauhan D; Li G; Auclair D; Hideshima T; Richardson P; Podar K; Mitsiades N; Mitsiades C; Li C; Kim RS; Munshi N; Chen LB; Wong W; Anderson KC
Blood; 2003 May; 101(9):3606-14. PubMed ID: 12480690
[TBL] [Abstract][Full Text] [Related]
19. 2-Methoxyestradiol induces endoreduplication through the induction of mitochondrial oxidative stress and the activation of MAPK signaling pathways.
Ting CM; Lee YM; Wong CK; Wong AS; Lung HL; Lung ML; Lo KW; Wong RN; Mak NK
Biochem Pharmacol; 2010 Mar; 79(6):825-41. PubMed ID: 19883629
[TBL] [Abstract][Full Text] [Related]
20. Class I beta-tubulin mutations in 2-methoxyestradiol-resistant acute lymphoblastic leukemia cells: implications for drug-target interactions.
Liaw TY; Salam NK; McKay MJ; Cunningham AM; Hibbs DE; Kavallaris M
Mol Cancer Ther; 2008 Oct; 7(10):3150-9. PubMed ID: 18852118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
